U.S. Compounding Pharmacies Market, By Therapeutic Area (Hormone Replacement Therapy, Pain Management, Specialty Drugs, Nutritional Supplements, and Others), By Route of Administration (Oral, Parenteral, and Others), By Application (Humans and Veterinary)

Published In : May 2024

Code : CMI3142

Pages :157

Formats :

Excel and PDF

Industry : Pharmaceutical

Market Concentration and Competitive Landscape

U.S. Compounding Pharmacies Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Increasing Inorganic Growth Strategies

Increasing adoption of inorganic growth strategies, such as acquisitions, is expected to drive the market growth over the forecast period. For instance, on April 10, 2024, Myonex, a global clinical trial supply company, announced that it had acquired Saveway Compounding Pharmacy, a compounding pharmacy in Delaware, U.S. The acquisition helped Myonex to better supply patients in clinical trials with medication and equipment as needed. It will also help the company expand its clinical trial designs and include direct-to-patient and home healthcare provider capabilities.

Key Players Insights